drugset / Trial / NCT00031135

Total Parenteral Nutrition-Associated Liver Disease

NCT00031135

Phase 2 Terminated 48 enrolled Northwestern University
RandomizedDouble-blindPrevention

Summary

This is a study to determine whether choline, when added to total parenteral nutrition (TPN), can help prevent the development of hepatic steatosis, a liver disease, in patients on TPN.

Timeline

Start
2001-09
Primary completion
Completion
2005-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Choline Other / unclassified

Indications